Biotech

All Articles

BioAge eyes $180M coming from IPO, exclusive positioning for obesity trials

.BioAge Labs is actually considering about $180 thousand in first profits from an IPO as well as a p...

Merck's LAG-3 combo neglects colorectal cancer cells period 3 research study

.A try by Merck &amp Co. to uncover the microsatellite dependable (MSS) metastatic colon cancer mark...

Spanish VC shuts $200M lifestyle sciences fund

.Spain-based Asabys Partners has actually shut a fund of 180 thousand europeans ($ 200 million), loa...

BioAge produces $198M from IPO as obesity biotech joins Nasdaq

.BioAge Labs is generating almost $200 thousand through its own Nasdaq IPO this morning, along with ...

Acadia takes BMS vet on board as chief executive officer-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of significant management hirings, shootings as ...

Cassava spends $40M over apparently deceptive Alzheimer's improve

.Cassava Sciences has agreed to spend $40 million to address an investigation into cases it created ...

Merck bags options on Evaxion's AI-designed injection prospects

.Merck &amp Co. has actually picked up alternatives on 2 Evaxion Biotech vaccine applicants, paying ...

Enanta's RSV antiviral crushes popular lots in obstacle study

.Enanta Pharmaceuticals has actually connected its own respiratory system syncytial virus (RSV) anti...

Biogen cans SAGE-324 partnership after important trembling fail

.Biogen has carried out the last ceremonies to its collaboration with Sage Rehabs on SAGE-324, junki...

AbbVie Parkinson's medication from $8.7 B Cerevel buyout ratings

.On the very same time that some Parkinson's illness drugs are actually being disputed, AbbVie has a...